Amyris

📍 Emeryville, United States🗓 Founded 2003👥 1,201 employees💰 Last funded Aug 2021
Biotechnology Research🌐 amyris.com
Website LinkedIn
Amyris (Nasdaq: AMRS) is a science and technology leader in the research, development and production of sustainable ingredients for the Clean Health & Beauty and Flavors & Fragrances markets. Amyris uses an impressive array of exclusive technologies, including state-of-the-art machine learning, robotics and artificial intelligence. Our ingredients are included in over 3,000 products from the world's top brands, reaching more than 200 million consumers. Amyris is proud to own three consumer brands - all built around its No Compromise® promise of clean ingredients: Biossance™ clean beauty skincare, Pipette™ clean baby skincare and Purecane™, a zero-calorie sweetener naturally derived from sugarcane. For more information, please visit www.amyris.com.
3
Total investors
0
Early stage
0
Mid stage
2
Late stage
2003
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
United Kingdom
1
Investor activity2009–2021 · investors recorded per year
2009220211
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Amyris?
Amyris has 3 investors on record on gritt.io and 2 late-stage investors.
When did Amyris last raise funding?
The most recent investment in Amyris recorded on gritt.io was in August 2021.
When was Amyris founded?
Amyris was founded in 2003.
What industry is Amyris in?
Amyris operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Amyris based?
Amyris is headquartered in Emeryville, United States.